Wegovy is a once-weekly injection approved for chronic weight management in obese adults or overweight adults with at least 1 weight-related health condition such as high blood pressure, heart disease, high cholesterol, or T2DM
NOVO NORDISK A/S, NOVO NORDISK INC
While encouraging, the generalisability of the studys findings is limited, as the trial was conducted exclusively in Chinese young adults
Semaglutide is the GLP-1 medication ingredient used in FDA-approved products such as Ozempic and Wegovy, and it should only be used with licensed-provider oversight
Briefly, approximately 20 mg of muscle sample was homogenized in 500 L of carnitine assay buffer and centrifuged at 13,000 g for 10 min
Injecting into Muscle or Vein: The medication should be injected into the fatty tissue under the skin, not the muscle